Bone marrow transplantation is often associated with multiple organ failure which is usually reversible. Oral mucositis and dysphagia, vomiting, diarrhoea, protein losing enteropathy, transient exocrine pancreatic impairment, hypoalbuminaemia, biochemical trace element and mineral de®ciencies are all common following transplantation and have profound nutritional consequences. Malnutrition affects negatively the clinical outcome. Nutritional support is provided to malnourished patients and those who suffer deterioration in nutritional status despite the provision of dietetic counselling. Only a few randomised studies comparing enteral with parenteral nutrition after transplant exist. Both enteral tube feeding (in the absence of mucositis) and parenteral nutrition are effective in maintaining nutritional status. However, enteral nutrition is associated with a better nutritional response and fewer complications than parenteral. With existing enteral and parenteral nutrition regimens close monitoring of trace element and mineral status is required.
Introduction
Bone marrow transplantation (BMT) is now a widely used treatment for several malignant and non-malignant disorders (Armitage, 1994) and offers radical cure to affected children. However, BMT is known to be associated with multiple organ failure, which is usually reversible. Transient intestinal failure following BMT is a common clinical problem because, unlike other forms of organatissue transplantation, BMT often requires the use of total body irradiation (TBI) in addition to immunosuppression. Cells with a rapid turnover, such as haemopoetic cells and immature enterocytes, are well recognised as highly susceptible to the effects of radiation and chemotherapy.
Early reactions following BMT such as mucositis, vomiting, diarrhoea and anorexia are well known (Wolford & McDonald, et al, 1988) . Nutrient intake in patients undergoing BMT is impaired by nausea, vomiting, dysgeusia, anorexia and multiple organ dysfunction (Day & Carpenter, 1993; Papadopoulou et al, 1996a) .
The aims of this work are to review the literature regarding the incidence of malnutrition in patients undergoing bone marrow transplantation, the effects of malnutrition on the clinical outcome, and the effects of the different techniques for providing nutritional support following bone marrow transplantation.
Indications for bone marrow transplantation as determinants of malnutrition
Malignancies are the main indications for BMT. The incidence of malnutrition among these patients is uncertain. Some researchers claim that children with cancer have a high incidence of wasting and stunting were 18% and 31% respectively even at the time of diagnosis (Tickard et al, 1983a, b; Berry et al, 1983; Kibirige et al, 1988; Rickard et al, 1989a, b) . Others do not support the above ®nding (Donaldson et al, 1981; Carter et al, 1983b; Besscho 1986; Tamminga et al, 1990) , while others report a high incidence of malnutrition (Aker et al, 1983; Berry et al, 1983) . Aker et al, reported that 16% of patients admitted for BMT due to acute myelogenous leukaemia had a weight less than 90% of ideal body weight (IBW), 17% had an arm muscle area (AMA) less than the 10th centile and 12% had arm fat area (AFA) less than 10th centile. According to the same study, 11% of the patients admitted for BMT due to acute lymphocytic leukaemia had an admission weight less than 90% of IBW, 21% an AMA less than the 10th centile and 6% an AFA less than the 10th centile. In our recent study in children undergoing BMT, wasting and stunting were present in 18% and 31%, respectively, of children admitted for BMT (Papadopoulou et al, 1998) .
Whether malnutrition is present at the time of diagnosis of malignancy or develops during therapy is still not clear. Some researchers claim that children with cancer have a high incidence of wasting and stunting (Rickard et al, 1983a,b; Kibirige et al, 1988; Rickard et al 1989a; b; (Berry et al, 1983) , even at the time of diagnosis, compared to a healthy population. Others do not support the above ®nding (Donaldson et al, 1981; Carter et al, 1983b; Besscho 1986; Tamminga et al, 1990) . Most clinicians, however, agree that intensive chemotherapy is often associated with a deterioration of nutritional status of the patients (Bernstein & Sigmundi, 1980; Dorr & Fritz 1980; Rickard et al, 1980; Bernstein et al, 1982; Donaldson et al, 1981; Nunnaly, 1983; Keenan 1989; Kennedy & Diamond, 1997; Papadopoulou et al, 1996a) .
The aetiology of malnutrition in patients with cancer is multifactorial (Table 1) . Abnormal host metabolism like that occurring in critically ill patients with multiple trauma or sepsis (Bistrian, 1983) , release of tumour-related factors such as cachectin, interleukins (IL-)1 and 6, interferon or tumour necrosis factor (TNF) (Beutler et al, 1986) , and increased basal metabolic rate together with a decreased energy intake (Bozetti et al, 1980; Lindmark et al, 1984; Norton et al, 1987; Lauvin et al, 1996; Tisdale, 1997) may all contribute to the development of cachexia. Glycogenolysis and lipolysis, proteolysis and gluconeogenesis are some of the metabolic events that may cause a profound nutritional insult to this group of patients (Moldawer et al, 1987; Fong et al, 1990; Falconer et al, 1994) . The role of TNF in patients with cancer is not entirely clear, as some researchers report that no correlation exists between TNF concentrations and the severity of malnutrition (Balkwill et al, 1987; Selby et al, 1987) . Furthermore, not all of the researchers agree about the changes in energy expenditure in children with malignancies. Bond et al (1992) reported similar energy expenditure at rest as well as energy intake in patients receiving chemotherapy for leukaemia and in healthy controls. No indication of wasting was evident in that group of patients. Moreover, recent studies in children undergoing maintenance chemotherapy for leukaemia showed an excessive weight gain due to a reduction in daily energy expenditure as a consequence of relative physical activity (Reilly et al, 1996; Warner et al, 1998) .
Gastrointestinal complications of chemotherapy are well recognised. Nausea and vomiting are common side-effects of intensive chemotherapy (Dorr & Fritz 1980; Rickard et al, 1980; Bernstein et al, 1982; Keenan, 1989) . The need for optimum emesis control during intensive chemotherapy is almost universal and the ef®cacy and safety of a number of antiemetic drugs have been evaluated (Hunter et al, 1991; Mehta et al, 1997) . A recent study in children undergoing BMT reported that oral ondansetron was superior to a combination of antiemetic drugs (perphenazine with diphenhydramine) on conditioning-related emesis control (Mehta et al, 1997) . Furthermore, anorexia and low oral intake are also associated with the use of chemotherapy: associations between the taste of foods and tumour growth per se (Bernstein & Sigmundi, 1980) , altered taste sensations which are often associated with the use of cyclophosphamide (Nunnaly, 1983) , and learned aversions for foods eaten before the administration of chemotherapy may all cause nausea and/or vomiting (Bernstein et al, 1982) . Oral mucositis is one of the more common side-effects of chemotherapy (Kennedy & Diamond, 1997) . Chemotherapy alters the integrity of the oral mucosa, the microbial ora, the composition of saliva, as well as the epithelial maturation. As a result, the patient may experience pain and dysphagia, leading to anorexia and reduced oral intake. Local antimicrobial therapy has been associated with a less severe mucositis in children undergoing BMT (Bondi et al, 1997) . Another study in a small group of 14 patients undergoing intensive chemotherapy for malignancies reported that oral supplementation with L-glutamine, a conditionally essential amino acid, was associated with a signi®cant decrease in the severity of oral mucositis (Skubitz & Anderson, 1996) .
Wasting and stunting have been reported to be present in patients with sickle-cell anaemia or thalassaemia (Zago et al, 1992 ; Caruso-Nicoletti et al, 1992). Zago et al reported signi®cantly worse nutritional status in 125 Brazilian patients with sickle-cell anaemia (aged from 7 months to 42 years) compared with the unaffected population (Zago et al, 1992) . In that study, although puberty was delayed, normal sexual maturation was attained later in life by most patients. Caruso-Nicoletti et al reported means of both weight and height to be 1 s.d. below the normal mean for age in 31 children with sickle-cell anaemia and 83 patients with thalassaemia (Caruso-Nicoletti et al, 1992) . Micronutrient de®ciencies are also common in children with thalassaemia (Uysal et al, 1993; Benso et al, 1995) . Excessive zinc excretion in urine has been reported to occur during chelation therapy (Shilivo et al, 1987; De Virgillis et al, 1988; Uysal et al, 1993) . More recently, Benso et al, reported data from a study in patients with thalassaemia, in whom zinc de®ciency was associated with growth retardation while its repletion was associated with a signi®cant improvement in growth (Benso et al, 1995) .
Nutritional insult following bone marrow transplantation
Weight loss and hypoalbuminaemia In patients undergoing BMT (both adults and children), an impairment in the nutritional status was observed following BMT (Cheney et al, 1987a; Lenssen et al, 1990; Taskinen & Saarinen 1996; Papadopoulou et al, 1996a) . Lenssen et al reported the prevalence of nutrition-related problems in 192 adult and child allogeneic BMT recipients (Lenssen et al, 1990) . According to that study, oral mucositis, xerostomia, dysgeusia and anorexia occurred in 8%, 18%, 3% and 8% of the patients, respectively. Furthermore, vomiting, diarrhoea and steatorrhoea developed 8%, 7% and 5% of the patients, respectively, following BMT. Impaired nutritional status was observed in 28% of the patients up to 12 months following BMT, indicating the need for ongoing nutritional monitoring of this group of patients after discharge (Lenssen et al, 1990) . In a more recent study in 42 children undergoing BMT, skeletal muscle protein reserves were assessed both by ultrasonography and by calculating the mid-arm muscle area from skinfold and arm circumference measurements (Taskinen & Saarinen, 1996) . According to that study, an 11% decrease in skeletal muscle protein reserves was observed during the ®rst month following BMT. In our recent study in 47 children undergoing BMT, vomiting and diarrhoea occurred in 40% and 57% of the patients following BMT (Papadopoulou et al, 1996a; Papadopoulou et al, 1998) . Poor nutritional status on admission was associated with a greater frequency of febrile and vomiting episodes and a longer hospital stay. The patients who developed diarrhoea following BMT showed a greater weight loss and reduced`well-being' compared with those patients who did not. Hypoalbuminaemia and biochemical zinc and selenium de®ciencies were all more severe in patients with diarrhoea. In adult patients, a negative nitrogen balance was reported after BMT, particularly in female patients (Cheney et al, 1987b) .
Various pathogenetic mechanisms have been postulated to explain the negative nitrogen balance following BMT: decreased protein synthesis due to cytotoxic chemotherapy (Hermann et al, 1981) , increased protein breakdown (Keller et al, 1990 ) and nitrogen loss due to proteinlosing enteropathy through watery stool (Weisdorf et al, 1983) or lung capillaries (Guiot et al, 1987) have all been implicated. Recent studies have shown a decrease in serum (van Hunsel et al, 1996; Haupt et al, 1997; Shenkin 1997) . According to these studies, infections and other injuries (such as ischaemic tissue necrosis) were associated with a release of several hormones, activation of complement and also a drastic increase in certain serum proteins (such as C-reactive protein) associated with a decrease in serum albumin (van Hunsel et al, 1996; Haupt et al, 1997) . In our recent study in children undergoing BMT, a signi®cant decrease in serum albumin was shown following BMT, particularly in children with diarrhoea and protein-losing enetropathy (Papadopoulou et al, 1996a) . Furthermore, a signi®cant negative correlation was found between the stool a1-antitrypsin concentrations and the fall in serum albumin both in patients who had and those who did not have diarrhoea following BMT, suggesting that protein loss from the gut was at least an important aetiological factor. The aetiology of protein-losing enteropathy (PLE) following BMT is multifactorial. Protein can be lost from the gut through an abnormal or in¯amed mucosal surface. Radiation has direct physical effects on the tissues of animals (Buell & Harding, 1989) . Graft-versus-host disease (GUHD) causes marked in¯ammation within the gut stroma, but also degeneration and necrosis of the glandular epithelium and the crypt cells, respectively (Appleton et al, 1993) . Recently, cytomegalourius (CMV) infection was reported to simulate GVHD histologically (Einsele et al, 1994) . PLE has also been reported in association with rotavirus infection in this context (Willoughby et al, 1988) . In our recent prospective study of the gastrointestinal consequences of BMT in children, we found that 91% of the investigated diarrhoeal episodes following BMT were associated with PLE (Papadopoulou et al, 1996a) . PLE was more severe in children with GVHD compared with other causes (rotavirus or CMV enteritis) and had profound nutritional consequences.
Micronutrient de®ciencies
Vitamin and trace element metabolism and absorption may be impaired as a result of chemotherapy in patients with cancer, chelation therapy in thalassaemia, and the conditioning regimens used for BMT. Vitamin K de®ciency (Carlin & Walker, 1991) , vitamin B 12 de®ciency (Milligan et al, 1987) , thiamin de®ciency (Rovelli et al, 1990 ) and magnesium depletion (June et al, 1985) , have all been reported to occur in adult patients following BMT. Similarly, biochemical zinc and copper de®ciencies have been reported in children with leukaemia (Beguin et al, 1985 (Beguin et al, , 1987 and solid tumours (Hrgovcic et al, 1986) , and also in children with thalassaemia receiving desferrioxamine (Uysal et al, 1993) . Decreased intake and absorption, and increased intestinal or urinary losses were some of the mechanisms of these de®ciencies.
A recent study in children undergoing BMT for malignancy reported a markedly elevated urinary selenium excretion after conditioning and during the course of BMT that was associated with biochemical selenium de®-ciency (Kauf et al, 1997) . In that study, glutathione peroxidase activity was markedly elevated, probably re¯ecting cytolytic processes. Disturbed tubular function was a postulated by the authors pathogenic mechanism for the elevated renal selenium excretion.
Recent studies have shown a decrease in plasma zinc level during an acute-phase in¯ammatory response suggesting that this is not`true' de®ciency (Ruz et al, 1995; Shenkin, 1997; Braunschweig et al, 1997) . Nevertheless, supplementation with parenteral zinc during an acute in¯ammation was shown to be associated with an exaggeration of the acute-phase response as evidenced by a signi®cantly higher febrile response (Braunschweig et al, 1997) . According to another study, the decrease in plasma zinc levels, which was observed during an acute-phase response, was associated with an increase in plasma copper (Shenkin, 1997) . In our recent study in children undergoing BMT, no changes in plasma copper levels were observed after BMT (unpublished data).
Magnesium de®ciency has been reported to occur even during the provision of nutritional support in children with Crohn's disease (Motil et al, 1985) . Recent studies in experimental animals (Nozue et al, 1993) and in humans (List et al, 1993) showed an association between hypomagnesaemia and the use of cyclosporin, possibly due to intracellular migration. Furthermore, hypomagnesaemia was reported to be associated with chemotherapy with cisplatin (Fossa et al, 1995) , as well as a combination of cisplatin and 5-¯uorouracil (Evans et al, 1995) , owing to increased losses of minerals with urine. Decreases in serum magnesium have been also reported to occur following BMT (June et al, 1985) . We reported recently that hypomagnesaemia was common in children following BMT and occurred irrespective of infections or diarrhoea, suggesting that its aetiology is probably multifactorial (Papadopoulou et al, 1997) .
Trace element plasma concentrations were examined recently in a group of adult patients undergoing BMT (Antilla et al, 1992) . According to that study, low zinc was observed before but not after BMT, while selenium and copper concentrations were unaltered. Low plasma zinc concentrations in these patients were predictive of mortality. In another retrospective study in BMT patients (Aker et al, 1983) , the incidence of low plasma zinc and copper levels was reduced by daily supplementation (4 mg zinc, 1 mg copper daily). However, neither of these studies reported whether the zinc status correlated with the nutritional status in these patients. Zinc is a cofactor in a number of metalloenzymes involved in nucleic acid synthesis (Wu & Wu, 1987) , and this may explain its importance in the maintenance of normal immunological function (Keen & Gershwin 1990 ). Therefore, it is possible that the disturbed metabolism of zinc is involved in the correlation between malnutrition and infection.
The clinical manifestations of zinc de®ciency (anorexia, skin rash, alopecia, diarrhoea, infections) are also common following BMT and it is therefore dif®cult to assess the frequency of zinc de®ciency on the basis of these ®ndings. Accurate biochemical zinc assessment is also dif®cult. The gold standard is estimation of concentration in tissue (Ruz et al, 1992; Arnaud et al, 1993) . However, the use of indirect methods for detecting zinc de®ciency, such as alkaline phosphatase activities (ALP; zinc-dependent metallo-enzyme), may be helpful in demonstrating functional zinc de®ciency in this group of patients (Ruz et al, 1992) . Cavan et al (1983) demonstrated signi®cant positive correlation between plasma zinc and ALP activities, whereas no correlation was found between either hair and plasma zinc or hair zinc and plasma ALP activities. Other investigators, however, failed to show any associations between ALP and either plasma zinc (Goode et al, 1991) , or leukocyte zinc concentrations (Rosner & Lee, 1972) . In Nutrition and BMT in children A Papadopoulou our recent study in children undergoing BMT, a signi®cant correlation between plasma zinc concentrations and ALP activities was shown and a signi®cant increase in ALP activities followed zinc supplementation to parenteral nutrition in 6 patients (Papadopoulou et al, 1996b) .
Nutritional status as a determinant of outcome
In children with chronic diseases, malnutrition is common and can have adverse effects on the course of the primary disease (Parsons et al, 1980; Chantler et al, 1988; Moy et al, 1990 ) and on the`well-being' of the patients (BroudeHeller et al, 1979) . Consistent with the ®ndings in adults, malnutrition has adverse effects on immune function in children, affecting both cellular and humoral defence mechanisms, polymorphonuclear leukocyte activity and complement activity (Teitell-Cohen et al, 1980; Salimonu et al, 1983; Chandra et al, 1984; Spurr et al, 1984; Ramirez et al, 1985) .
In children with cancer, malnutrition seems to have an adverse effect on clinical outcome, although the precise nature of this relationship is not fully understood (Donaldson et al, 1981; van Eys, 1985; Taj et al, 1993) . In childhood leukaemia, malnutrition is associated with a higher rate of infection (Taj et al, 1993) . Higher infection rate was also reported in malnourished children with metastatic bone disease compared to well-nourished ones (van Eys et al 1980) . Furthermore, an association was found between the degree of malnutrition and the relapse rate in children with solid tumours (Donaldson et al, 1981) . The same study reported decreased survival in children with malignancies whose weight for height ratio was 80% of median for age compared to well-nourished ones. Similarly, Rickard et al reported a shorter remission in malnourished children with neuroblastomas compared with well-nourished children (Rickard et al, 1983b) . Merritt et al (1983) reported that only 17% of malnourished patients with cancer survived 2 years from the initial assessment, compared with 70% of well-nourished patients. A slightly improved survival was also reported in well-nourished patients with advanced neuroblastoma (van Eys, 1985) . In patients undergoing BMT, marrow recovery correlated signi®cantly with nutritional status at diagnosis (Yokohama et al, 1989) . In our recent study in children undergoing BMT, poor nutritional status was associated with a greater frequency of febrile and vomiting episodes and longer hospital stay (Papadopoulou et al, 1998) .
The ®nancial cost of malnutrition is also important, as it has been reported that the admission of a malnourished patient with a major complication costs four times than that of a well-nourished one with an uncomplicated course (Reilly et al, 1987) . In another study, malnutrition was reported to be associated with more than doubled hospital charges as a result of to a longer hospital stay (Robinson et al, 1987) .
Nutritional assessment
Nutritional assessment is essential for proper diagnosis and treatment of malnutrition. Numerous anthropometric indices are available that re¯ect body composition changes. However, it is well known that¯uid intake and output are unstable in critically ill patients. The administration of uids may sometimes lead to over-hydration, while diarrhoea and vomiting may lead to dehydration. Both situations reduce the reliability of weight-related indices in assessing nutritional status (Cheney et al, 1987) . Moreover, weight frequently remains stable despite negative nitrogen balance and loss of lean body mass owing to changes in hydration (Cittere et al, 1983) .
Anthropometry can be useful in BMT patients if measurements are obtained serially (Cheney et al, 1987) . Midarm circumference (MAC), is said to be the most reliable anthropometric index in children with solid tumours (Smith et al, 1990) , while skinfold measurements are also considered helpful in assessing changes in body stores of muscle and fat (Frisancho & Flegel, 1982) . Isotope dilution studies have been suggested as another technique for monitoring the body composition changes in patients receiving nutritional support (Szeluga et al, 1984) . With this method, total body water and extracellular¯uid volume are measured using 3 H 2 O and 82 Br respectively as tracers, and body cell mass is calculated afterwards using various calculation methods. Cheney et al reported that body weight correlated poorly with body cell mass or¯uid volume changes, assessed using tracer dilution techniques, in a group of 9 patients aged 12 ± 35 years undergoing BMT (Cheney et al, 1987) . However, a good correlation was reported between changes in arm muscle area and changes in body cell mass. De Graaf et al also reported a dissociation of body weight and lean body mass in children and adolescents receiving chemotherapy for cancer and suggested the use of deuterium oxide dilution techniques for a serial monitoring of lean body mass in this group of patients (de Graaf et al, 1987) . More recently, bioelectrical impedance was validated for estimating free fat mass in a group of 56 children and young adults and was found to give reliable estimates compared with isotope dilution techniques (Suprasongsin et al, 1995) . Bioelectrical impedance is a quick, portable, reliable, simple and noninvasive method for monitoring body composition. However, its use in children undergoing BMT has not yet been validated.
Nutritional intervention following BMT: Which route?
Indications and strategies of nutritional support The nutritional targets of supplementary nutritional support in children undergoing BMT are: (i) correction of wasting, and (ii) maintenance of the nutritional status during chemotherapy (Papadopoulou et al, 1995b) . The indications for providing nutritional support are given in Table 2 .
Methods used for providing nutritional support to the patients include dietetic counselling with nutritional supplements aiming at achieving a voluntary oral intake of high energy; nasogastric or gastrostomy tube feeding; and parenteral nutrition. The role of conventional diet in maintaining nutritional status during insult A number of studies have shown that conventional feeding with added supplements is insuf®cient in preventing or reversing weight loss in children with leukaemia ± lymphoma (Hays et al, 1983) , Wilms' tumours (Rickard et al, 1980) , advanced neuroblastoma (Rickard et al, 1985) , and a variety of tumours requiring abdominal irradiation (Donaldson et al, 1984) . Rickard et al reported a deterioration in the nutritional status of children with Wilm's tumour who did not receive PN compared with those who did (Rickard et al, 1980) . Similarly, Donaldson et al also claimed a deterioration of the nutritional status in 1/4 of the children who had radiotherapy due to abdominal and pelvic malignancies and did not receive parenteral nutrition (Donaldson et al, 1982) . In our recent study in children undergoing BMT, the changes in weight and mid-arm circumference z-scores were greater in children receiving supplementary nasogastric tube feeding than in those who received conventional diet with added supplements and close dietetic counselling (Papadopoulou et al, 1997) . The need, therefore, to provide nutritional support to this group of patients is almost universal.
The role of parenteral nutrition (PN)
Until recently, PN has been considered to be the treatment of choice for providing nutritional support in patients with cancer (Apelgren & Wilmore, 1981; Weisdorf et al, 1987) . However, the nutritional bene®ts from the use of PN in these patients and its role in the outcome and survival are questioned. Hays et al compared outcomes, including maintenance of body cell mass and response to skin test antigens, in children with leukaemia who received PN and those who received a standard diet (Hays et al, 1983) . White blood cell granulocyte and platelet counts were higher in the patients receiving PN without any reduction in the incidence of febrile episodes or the clinical outcome. In another study in BMT patients, PN was compared with standard diet (Weisdorf et al, 1987) . Calorie and protein intake were signi®cantly higher in patients receiving PN compared with patients receiving conventional diet and their survival rate was signi®cantly better. However, no differences were shown with respect to duration of hospitalisation, episodes of sepsis or incidence of GVHD. A favourable effect of PN on the maintenance of body weight in children undergoing BMT was reported in another study, although no bene®cial effects were shown with respect to marrow recovery (Yokoyama et al, 1989) . Other clinical trials have raised questions about the role of PN, claiming no real bene®ts from its use (Lim et al, 1981; van Eys et al, 1982) . Furthermore, the use of PN was reported to be associated with more frequent febrile episodes, anaemia and pulmonary dysfunction compared with conventional ward diet in adults with cancer (Mullen, 1981) . In our recent prospective study in children undergoing BMT, PN succeeded in maintaining the nutritional status of the patients following BMT (Papadopoulou et al, 1998) . However, the duration of PN did not alter the improvements in weight and mid-arm circumferences. Moreover, PN was associated with more frequent exocrine pancreatic impairment, more common biochemical zinc de®ciency and more severe biochemical selenium de®-ciency compared with nasogastric tube feeding.
The role of the supplementation of PN with speci®c nutrients in patients undergoing BMT has been investigated recently. Glutamine is an important metabolic substrate for rapidly proliferating cells and has multiple effects on the immune system, on intestinal function and on protein metabolism (Roth et al, 1996) . Recent studies in patients (adult and child) undergoing BMT showed that the supplementation of PN with glutamine was associated with an increased total lymphocyte count and CD4 and CD8 Tlymphocyte counts in peripheral blood compared with standard glutamine-free PN regimen (Ziegler et al, 1998) ; improved nitrogen balance, reduced incidence of infections, shortened hospital stay and signi®cant cost savings compared to the standard PN regimen (Mobrahan, 1992; Ziegler et al, 1992; MacBurney et al, 1994) .
The role of enteral nutrition (EN)
Enteral nutrition is more physiological, cheaper and simpler to provide than PN. Its role in children with chronic disorders has been studied extensively. It was associated with an arrest in the deterioration of lung function in children with cystic ®brosis (Levy et al, 1985; Boland et al, 1986; Shepherd et al, 1986) ; reduced spasticity in children with cerebral palsy (Patrick et al, 1986) ; a reduction in the need for surgery in infants with gastro-oesophageal re¯ux (Ferry et al, 1983) ; better growth in children with Crohn's disease, compared with those given corticosteroids (Belli et al, 1988; Papadopoulou et al, 1995b) ; and achievement of weight gain in children with congenital heart disease (Bougle et al, 1986) and in children with chronic renal failure (Rees et al, 1989) . Furthermore, enteral feeds have a bene®cial effect on gut mucosal barrier function in experimental animals (Inoue et al, 1989) , and in humans (Moore et al, 1989) .
The provision of EN has ®nancial implications, as a reduction in cost per day has been reported in adult and child patients owing to the shortening of the hospital stay and the decrease in complication rates (Twomey & Patchings, 1985; Jendteg et al, 1987; Ford et al, 1997) . Compared to parenteral nutritions, EN is simpler to provide, as it does not require a special hospital infrastructure (Rollins 1993) , and cheaper (Szeluga et al, 1987; Payne-James et al 1990) .
In children with cancer, enteral tube feeding (ETF) was well tolerated and had a bene®cial effect on nutritional status (Goyens & Otten, 1983; Nicol et al, 1987; Smith et al, 1992) . Goyens & Otten reported improved weight gain in 12 children with leukaemia who received ETF. Nicol et al also reported weight gain in children with unspeci®ed cancer who received nasogastric feeding. However, neither study was randomised or controlled. More recently, Smith et al, reported a randomised trial in a small group of 12 children undergoing treatment for malignancies (Smith et al, 1992) . The provision of nasogastric feeding in six cases was well tolerated and was associated with an improvement in nutritional status and in`well-being' compared with conventional dietetic counselling alone. Others, however, consider that`forced' enteral feeding is an unacceptable option for nutritional support in children with cancer (Rickard et al, 1982) . Two prospective, randomised studies comparing EN with PN were conducted in adult patients undergoing BMT (Szeluga et al, 1987; Mulder et al, 1989) . Szeluga et al reported fewer complications in patients receiving a modi®ed EN programme (counselling andaor ETF), comparing with PN. Similarly, Mulder et al reported a lower incidence of diarrhoea in patients receiving partial Nutrition and BMT in children A Papadopoulou PN plus EN than in those receiving PN alone. A recent anecdotal report in a child undergoing BMT claimed that long-term (duration of 300 days) enteral nutrition by a gastrostomy was feasible. It was associated with an improvement of the nutritional status of the child and maintenance of normal visceral protein stores (RingwaldSmith et al, 1995) . In our recent prospective study in children undergoing BMT, ETF was feasible following BMT and was not associated with nutrient malabsorption or excessive gastrointestinal disturbances (Papadopoulou et al, 1997) . Moreover, a signi®cant positive correlation was found between the duration of feeds and the improvement in weight and MAC. However, ETF did not succeed in preventing biochemical nutrient and trace element de®cien-cies following BMT.
Feeds recommended for ETF following BMT
In our recent study in children undergoing BMT, a diet containing lactose and cow's milk protein was well tolerated by all of the patients who did not have diarrhoea, without any signs of nutrient malabsorption (Papadopoulou et al, 1997) . However, the high incidence of carbohydrate intolerance (mainly of lactose) that was shown in children with diarrhoea, particularly due to GVHD and to rotavirus infection, means that a lactose-free diet may be more bene®cial to these patients.
A variety of feeds had been used in previous studies in adults with cancer (Johnston et al, 1981; Block et al, 1981) . Donaldson et al claimed successful management of radiation enteritis in children with a low-residue, low-fat and gluten-, lactose-and cow's milk protein-free diet (Donaldson et al, 1984) . However, it is not clear from that study whether the improvement was due to the speci®c dietary manipulations or just to nutritional repletion.
Recent experimental studies suggest that glutamine supplementation of EN improves intestinal mucosal integrity, reduces the incidence of bacterial translocation and improves nitrogen balance (Fox et al, 1988; Gianotti et al, 1995) . However, its use in children with cancer is still anecdotal (Ford et al, 1997) . Furthermore, dietary lipids (o-3-fatty acids) have been shown to boost immunological function (Alexander et al, 1986; Endres et al, 1989) , but their use in children needs further investigation.
Multidisciplinary team approach to nutritional support A multidisciplinary team approach is the best way of providing safe, appropriate and effective nutritional support. The nutritional care teams comprise a clinician with special experience in nutrition, a nurse specialist, a biochemist and a dietician. Their responsibilities are shown in Table 3 . The presence of a multidisciplinary nutritional care team in regional hospitals can improve the quality of the nutritional support and also reduce the cost (Brown et al 1987; Puntis & Booth 1990) . Reported advantages of a nutritional care team include a reduction of central venous catheter sepsis and mechanical catheter-related problems, a decrease in metabolic complications associated with PN, and an increased use of enteral in place of parenteral nutrition (Hamaoui, 1987) .
Conclusions and nutritional recommendations
Gastrointestinal damage following BMT is complex and has profound nutritional consequences. Nutritional considerations for children undergoing BMT are summarised in Table 4 . The provision of nutritional support to this group of patients BMT is important for maintaining nutritional status. Establishment of multidisciplinary nutritional care teams is essential for nutritional support to be at the highest standard. Further prospective, randomised studies are needed to assess the ef®cacy and safety of specialised nutritional strategies. Table 4 Nutritional recommendations to children undergoing BMT Malnutrition should if possible, be treated before the admission for BMT. Supplementary feeding (nasogastric or parenteral) should be provided to patients who suffer deterioration in nutritional status following BMT, despite the provision of dietetic counselling. Nasogastric feeding is preferable to parenteral nutrition in the absence of oral mucositis. A normal diet is appropriate for asymptomatic patients, while a lowresidue, gluten-and lactose-free diet is indicated for patients with diarrhoea. Parenteral nutrition should be used in patients with oral mucositis or those patients who do not tolerate enteral feeds owing to vomiting anda or diarrhoea. Parenteral nutrition following BMT should contain selenium. A close monitoring of the mineral and trace element status is required during nutritional support. A multidisciplinary team approach to nutritional care is important.
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